0 Evaluaciones

ID

14007

Descripción

This is an open-label (all people know the identity of the intervention), multicenter study in genotype 1 chronic HCV infected liver transplant patients who will be treated for 12 weeks with telaprevir 750 mg every 8 hours given in combination with Peg-IFN-alfa-2a and ribavirin followed by 36 weeks of treatment with Peg-IFN-alfa-2a and ribavirin alone. The total treatment duration will be 48 weeks. Safety will be evaluated throughout the study and will include evaluations of adverse events, clinical laboratory tests, electrocardiogram, vital signs, and physical examination. NCT01571583

Palabras clave

  1. 22/3/16 22/3/16 -
Titular de derechos de autor

CC BY-NC 3.0

Subido en

22 de marzo de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :


    Sin comentarios

    Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

    VX-950HPC3006 NCT01571583 First Intakes Of Study Medication

    VX-950HPC3006 NCT01571583 First Intakes Of Study Medication

    First Intakes Of Study Medication
    Descripción

    First Intakes Of Study Medication

    actual date and time of first intake of telaprevir during this trial
    Descripción

    first intake of telaprevir

    Tipo de datos

    datetime

    Alias
    UMLS CUI [1,1]
    C1876229
    UMLS CUI [1,2]
    C3174092
    UMLS CUI [1,3]
    C0205435
    UMLS CUI [1,4]
    C0011008
    actual date of first intake of ribavirin during this trial
    Descripción

    date of first intake of ribavirin

    Tipo de datos

    datetime

    Alias
    UMLS CUI [1,1]
    C0035525
    UMLS CUI [1,2]
    C3174092
    UMLS CUI [1,3]
    C0205435
    UMLS CUI [1,4]
    C0011008
    actual date and time of first administration of PEG-IFN during this trial
    Descripción

    date and time of first administration of PEG-IFN

    Tipo de datos

    datetime

    Alias
    UMLS CUI [1,1]
    C0907160
    UMLS CUI [1,2]
    C3174092
    UMLS CUI [1,3]
    C0205435
    UMLS CUI [1,4]
    C0011008

    Similar models

    VX-950HPC3006 NCT01571583 First Intakes Of Study Medication

    Name
    Tipo
    Description | Question | Decode (Coded Value)
    Tipo de datos
    Alias
    Item Group
    First Intakes Of Study Medication
    first intake of telaprevir
    Item
    actual date and time of first intake of telaprevir during this trial
    datetime
    C1876229 (UMLS CUI [1,1])
    C3174092 (UMLS CUI [1,2])
    C0205435 (UMLS CUI [1,3])
    C0011008 (UMLS CUI [1,4])
    date of first intake of ribavirin
    Item
    actual date of first intake of ribavirin during this trial
    datetime
    C0035525 (UMLS CUI [1,1])
    C3174092 (UMLS CUI [1,2])
    C0205435 (UMLS CUI [1,3])
    C0011008 (UMLS CUI [1,4])
    date and time of first administration of PEG-IFN
    Item
    actual date and time of first administration of PEG-IFN during this trial
    datetime
    C0907160 (UMLS CUI [1,1])
    C3174092 (UMLS CUI [1,2])
    C0205435 (UMLS CUI [1,3])
    C0011008 (UMLS CUI [1,4])

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial